{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:41:35Z","timestamp":1794717695932,"version":"4.9.1"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>Glucocorticoids are highly effective in the therapy of inflammatory diseases. Their value, however, is limited by side effects. The discovery of the molecular mechanisms of the glucocorticoid receptor and the recognition that activation and repression of gene expression could be addressed separately opened the possibility of achieving improved safety profiles by the identification of ligands that predominantly induce repression. Here we report on ZK 245186, a novel, non\u2010steroidal, low\u2010molecular\u2010weight, glucocorticoid receptor\u2010selective agonist for the topical treatment of inflammatory dermatoses.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Pharmacological properties of ZK 245186 and reference compounds were studied in terms of their potential anti\u2010inflammatory and side effects in functional bioassays<jats:italic>in vitro<\/jats:italic>and in rodent models<jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Anti\u2010inflammatory activity of ZK 245186 was demonstrated in<jats:italic>in vitro<\/jats:italic>assays for inhibition of cytokine secretion and T cell proliferation.<jats:italic>In vivo<\/jats:italic>, using irritant contact dermatitis and T cell\u2010mediated contact allergy models in mice and rats, ZK 245186 showed anti\u2010inflammatory efficacy after topical application similar to the classical glucocorticoids, mometasone furoate and methylprednisolone aceponate. ZK 245186, however, exhibits a better safety profile with regard to growth inhibition and induction of skin atrophy after long\u2010term topical application, thymocyte apoptosis, hyperglycaemia and hepatic tyrosine aminotransferase activity.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>ZK 245186 is a potent anti\u2010inflammatory compound with a lower potential for side effects, compared with classical glucocorticoids. It represents a promising drug candidate and is currently in clinical trials.<\/jats:p><jats:p>This article is part of a themed issue on Mediators and Receptors in the Resolution of Inflammation. To view this issue visit<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www3.interscience.wiley.com\/journal\/121548564\/issueyear?year=2009\">http:\/\/www3.interscience.wiley.com\/journal\/121548564\/issueyear?year=2009<\/jats:ext-link><\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00238.x","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T11:43:19Z","timestamp":1241696599000},"page":"1088-1103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases"],"prefix":"10.1111","volume":"158","author":[{"given":"H","family":"Sch\u00e4cke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TM","family":"Zollner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WD","family":"D\u00f6cke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Rehwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Jaroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Skuballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Z\u00fcgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Asadullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,16]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"309","article-title":"Extensive visual loss with topical facial steroids","volume":"18","author":"Aggarwal RK","year":"1993","journal-title":"Eye"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707746"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.3.435"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.309"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2001.00001.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/08923979109019704"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.1975"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0538"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01269.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206778194132"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1982.tb03140.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.2.257"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.4.6.847"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.22164025.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000053836"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03473.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2007.04.014"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2002-0355"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0505554102"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200403113501122"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00787.x"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00651.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/archderm.1976.01630350035009","article-title":"Induction of glycosuria and hyperglycemia by topical corticosteroid therapy","volume":"112","author":"Gomez EC","year":"1976","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06726.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex (17\u2010hydroxy\u201011\u2010dehydrocorticosterone: Compound E) and the pituitary adrenocorticotropic hormone on rheumatoid arthritis. Preliminary report","volume":"24","author":"Hench PS","year":"1949","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2340\/00015555712931","article-title":"The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids","volume":"71","author":"van den Hoven WE","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050222"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.7108"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70224-H"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700506"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb02279.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/j.1460-2075.1992.tb05283.x","article-title":"Interference between pathway\u2010specific transcription factors: glucocorticoids antagonize phorbol ester\u2010induced AP\u20101 activity without altering AP\u20101 site occupation in vivo","volume":"11","author":"K\u00f6nig H","year":"1992","journal-title":"EMBO J"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1353"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.03626.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb04008.x"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000422371"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.14.12.1527"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00597.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01259-0"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.17.1.37"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.038794"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00164a007"},{"key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2340\/0001555559245248","article-title":"Systemic effects of local treatment with high doses of potent corticosteroids in psoriatics","volume":"59","author":"Nilsson JE","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80305-3"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2470"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81183-6"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2000.118"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.24.7168"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00297-8"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0300372101"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.18.3.339"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.12.7063"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-001-0276-9"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-7775-6_8"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357022962"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1210\/mend.11.9.9979"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1159\/000237208"},{"key":"e_1_2_9_59_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2340\/0001555572403406","article-title":"The hairless mouse model for assaying the atrophogenicity of topical corticosteroids","volume":"72","author":"Woodbury R","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.20047"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19623.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T09:08:04Z","timestamp":1739092084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00238.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00238.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"2009-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}